Top Markets
#1 GoPlus Security GoPlus Security +40.91%
#2 Tutorial Tutorial +21.27%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.85%
#4 Pons Pons +18.51%
#5 Status Status +14.44%
#6 SkyAI SkyAI +13.40%
#7 Verus Coin Verus Coin +13.11%
#8 BankrCoin BankrCoin +9.34%
#9 Nillion Nillion +8.72%
#10 Ontology Gas Ontology Gas +8.06%
Coin of the day
GoPlus Security GoPlus Security
Innstillinger
Språk
NORSK
Valuta
USD
Tema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rangering i aksjer #33743
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Aksjekurs
$4.58
Sist synkronisert: 2025-05-09
Markedsverdi
$6.98M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel NeuroMetrix, Inc. (NURO)

Kategori

Healthcare
Inntekter for NeuroMetrix, Inc. (NURO)
Inntekter i Dec 2024 TTM: $-7.81M
Ifølge NeuroMetrix, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $-7.81M. I 2023 hadde selskapet et resultat på $-6.53M, en nedgang sammenlignet med resultatet i 2022, som var $-4.42M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for NeuroMetrix, Inc. fra 2001 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-7.81M 0.00%
2024 $-7.81M 19.55%
2023 $-6.53M 47.84%
2022 $-4.42M 93.58%
2021 $-2.28M 9.05%
2020 $-2.09M -44.55%
2019 $-3.77M -16,083.96%
2018 $23.61K -100.18%
2017 $-12.86M -13.77%
2016 $-14.91M 62.32%
2015 $-9.19M 18.30%
2014 $-7.77M -3.15%
2013 $-8.02M -19.87%
2012 $-10.01M 0.26%
2011 $-9.98M -41.33%
2010 $-17.01M -99.86%
2009 $-11.92B 56,302.52%
2008 $-21.13M 152.19%
2007 $-8.38M -287.82%
2006 $4.46M 358.34%
2005 $973.26K -100.01%
2004 $-13.51B 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -96,320.18%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -66,048.81%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -71,365.19%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -49,561.60%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -18,260.26%
US